By The Tribune Content Agency
Newly back in the CEO chair at UnitedHealth Group, Stephen Hemsley on Monday vowed to address a series of lightning-rod issues that have heightened public scrutiny of the company.
That includes fresh reviews of the Eden Prairie company’s pharmacy business, the way it scores Medicare patients’ health risks and its care management practices.
But Hemsley, the longtime executive who resumed his role as CEO last month, kept his cards close to the vest during the company’s annual meeting Monday, offering almost no specifics about the new reviews. He also apologized for recent financial missteps that have shocked investors and prompted an unprecedented decline in UnitedHealth Group’s share price.
Read more at: https://www.miamiherald.com/news/business/article307750475.html#storylink=cpy
